Connecticut-based Hyperfine Research said its new point-of-care imaging tool carries a fraction of the cost and weight of a traditional magnetic resonance machine. 

Emory University recently devised a detailed process to ensure that such tests are delivered in a uniform fashion across its vast clinical enterprise.

Idaho-based International Isotopes has received U.S. Food and Drug Administration approval for its radioactive therapeutic agent used to treat thyroid cancers.

A recent review of pivotal cancer drug trials suggests that CVD and adverse cardiovascular outcomes are underreported in studies of new cancer therapies, despite an increasing risk of cardiotoxicity in oncological drugs.

Randall Batemen, MD, principal investigator of the research and a neurologist at Washington University in St. Louis, told the New York Times the results were "really crushing."

Deep learning-based AI models can improve the segmentation of white matter in 18F-FDG PET/CT images, according to a new study published in the Journal of Digital Imaging. This helps radiologists with the early diagnosis of neurodegenerative disease.

Caption Guidance serves as an accessory to certain diagnostic systems, aiding clinicians in capturing high-quality cardiac scans. 

The National Institute on Aging awarded Wake Forest School of Medicine a five-year grant to examine if a novel PET tracer can help researchers tackle the disease.